TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
POA Pharma Scandinavia AB
Closing information (x1000 NOK)
| Closing information | 2023/09 | 2022/09 | 2021/09 |
| Turnover |
93,428
|
81,313
|
78,627 |
| Financial expenses |
180
|
22
|
10 |
| Earnings before taxes |
1,451
|
3,777
|
-2,489 |
| EBITDA |
2,429
|
4,668
|
-1,864 |
| Total assets |
51,767
|
39,115
|
36,577 |
| Current assets |
49,510
|
36,692
|
33,305 |
| Current liabilities |
25,184
|
13,606
|
13,434 |
| Equity capital |
26,583
|
25,509
|
23,143 |
| - share capital |
98
|
96
|
100 |
| Employees (average) |
13
|
12
|
14 |
Financial ratios
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Solvency |
51.4%
|
65.2%
|
63.3% |
| Turnover per employee |
7,187
|
6,776
|
5,616 |
| Profit as a percentage of turnover |
1.6%
|
4.6%
|
-3.2% |
| Return on assets (ROA) |
3.2%
|
9.7%
|
-6.8% |
| Current ratio |
196.6%
|
269.7%
|
247.9% |
| Return on equity (ROE) |
5.5%
|
14.8%
|
-10.8% |
| Change turnover |
10,292
|
5,864
|
31,210 |
| Change turnover % |
12%
|
8%
|
66% |
| Chg. No. of employees |
1
|
-2
|
4 |
| Chg. No. of employees % |
8%
|
-14%
|
40% |
Total value of public sale
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.